"The pension funds of millions of people across the world, including teachers, public sector workers, health staff and academics in the UK and US, are heavily exposed to the plummeting coal sector, a Guardian analysis has revealed."
"BRUSSELS -- Talks on phasing out a form of coal subsidies ended in stalemate as Japan, the biggest user of the aid, led calls for more time in defiance of this week's G7 pledge on fossil fuel subsidies, sources said."
"Selling seeds and pesticides used to be a sleepy, slow-moving business. That was, until about 20 years ago, when the chemical company Monsanto introduced genetically modified crops and started buying up seed companies. Ever since, companies in this industry have been maneuvering like hungry fish in a pond, occasionally dining on pieces of each other, hoping to survive through size and speed."
"In 25 years, Kentucky’s energy landscape will look dramatically different than it does now. As Energy and Environment Secretary Len Peters told a legislative committee last week, Kentucky is already facing the loss of the majority of its coal fleet over the next 25 years, and that’s without the EPA’s upcoming greenhouse gas regulations."
"Directors of the Norwegian sovereign wealth fund, an investment pool worth more than $900 billion, will sell many of its coal industry holdings, officials said last week."
"The Organization of the Petroleum Exporting Countries is highly unlikely to agree to curbs on its members’ oil output at its meeting here on Friday, even though oil prices are about 40 percent lower than a year ago, OPEC officials and analysts say."
"Ikea, the world’s biggest furniture retailer, plans to spend €1bn ($1.13bn) on renewable energy and steps to help poor nations cope with climate change, the latest example of firms upstaging governments in efforts to slow warming."
"Georgetown University's board of directors approved a plan Thursday to divest its endowment from coal companies."
The problem of growing bacterial resistance to antibiotics is being compounded by the decisions of many drug companies to stop developing and making new antibiotics. The reason: they are not making money.
Advertisement 
